Cite
MLA Citation
Rajappa Kenchappa et al.. “DDDR-28. EGFR AND SRC-MEDIATED ACTIVATION OF STAT3 DRIVES RESISTANCE TO MITOTIC INHIBITORS IN GLIOBLASTOMA, AND CAN BE REVERSED WITH FDA-APPROVED DRUGS.” Neuro-oncology, vol. 24, n.d., p. vii105. http://access.bl.uk/ark:/81055/vdc_100169742560.0x00003a